Stroke and Vascular Neurology

Papers
(The TQCC of Stroke and Vascular Neurology is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Oxidised low-density lipoprotein and adverse outcome in patients with acute mild ischaemic stroke or high-risk TIA: a secondary analysis of the INSPIRES randomised clinical trial98
Letter to the editor: risk factors for cervical artery dissection – a systematic review with meta-analysis92
Efficacy of immediate anti-hypertensive treatment in patients with acute ischaemic stroke stratified by mean arterial pressure and pulse pressure: a secondary analysis of the China Antihypertensive Tr77
Contact aspiration versus stent retriever thrombectomy for acute basilar artery occlusion (ANGEL-COAST): rationale and design of a multicentre, prospective, randomised, open-label, blinded-endpoint tr57
CerebrAlcare Pills on CereBral Small VesseL DiseasE (CABLE) trial: rationale and design53
Long-term clinical outcome after extracranial–intracranial bypass surgery for atherosclerotic vessel occlusion in patients with diminished cerebrovascular reserve capacity and recurrent ischaemic even45
Dural sinus septum: an underlying cause of cerebral venous sinus stenting failure and complications33
Photochemically induced thalamus infarction impairs cognition in a mouse model32
Efficacy and safety of Y-3 intracalvariosseous injection versus intravenous injection in the treatment of acute large hemispheric infarction (SOLUTION-2): rationale and design of a multicentre, prospe30
MetS in the prediction of asymptomatic intracranial arterial stenosis: the potential mediating role of hsCRP29
Multiomics genetic insights into potential molecular targets for intracranial aneurysm28
Mechanical thrombectomy with combined stent retriever and contact aspiration versus stent retriever alone for acute large vessel occlusion: data from ANGEL-ACT registry26
Associations of albumin, globulin and albumin-to-globulin ratio with cerebral small vessel disease25
Prediction of futile recanalisation after endovascular treatment in acute ischaemic stroke: development and validation of a hybrid machine learning model25
30 years of thrombolysis for ischaemic stroke: expanded agents, widened windows and accelerated delivery24
Stepwise improvement in intracerebral haematoma expansion prediction with advanced imaging: a comprehensive comparison of existing scores23
Characteristics, temporal trends and outcomes of intravenous thrombolysis in Chinese patients aged>80 years who had a stroke23
Intravenous tenecteplase compared with alteplase for minor ischaemic stroke: a secondary analysis of the AcT randomised clinical trial22
Association of socioeconomic status with intracranial arterial plaque: mediated by cardiometabolic risk factors22
Acute right insular ischaemic lesions and poststroke left ventricular dysfunction22
Loberamisal injection for the treatment of acute ischaemic stroke: a multicentre, randomised, double-blind, placebo-controlled phase II clinical trial21
KRAS mutation-induced EndMT of brain arteriovenous malformation is mediated through the TGF-β/BMP-SMAD4 pathway20
Frequency, predictors and cardiovascular outcomes associated with transthoracic echocardiographic findings during acute ischaemic stroke hospitalisation20
LRRC8A in endothelial cells contributes to the aberrant blood-brain barrier integrity in ischaemic stroke20
Adjunct tirofiban treatment after successful endovascular thrombectomy recanalisation in acute anterior circulation ischaemic stroke (ATTRACTION): protocol of a multicentre, prospective, double-blinde20
Pipeline Embolization Device for intracranial aneurysms presenting with mass effect: a large Chinese cohort19
Tongxinluo capsule in the treatment of cerebral small vessel disease: protocol of a randomised, double-blind, placebo-controlled, multicentre clinical study (TOPS-CSVD)19
Thrombus migration in patients with acute ischaemic stroke undergoing endovascular thrombectomy19
Poststroke motor, cognitive and speech rehabilitation with brain–computer interface: a perspective review18
Detailed phenotype of RNF213 p.R4810K variant identified by the Chinese patients with acute ischaemic stroke or transient ischaemic attack18
Development of machine learning-based models to predict 10-year risk of cardiovascular disease: a prospective cohort study18
Endovascular treatment for basilar artery occlusion: a meta-analysis18
Discontinuation of antiplatelet therapy after stent-assisted coil embolisation of cerebral aneurysm: a nationwide cohort study17
Arteriolosclerosis differs from venular collagenosis in relation to cerebrovascular parenchymal damages: an autopsy-based study17
Low LDL-C level and intracranial haemorrhage risk after ischaemic stroke: a prospective cohort study17
STING mediates microglial pyroptosis via interaction with NLRP3 in cerebral ischaemic stroke16
Ten-year follow-up investigation of stroke risk in systemic lupus erythematosus16
Treatment with intravenous alteplase in ischaemic stroke patients with onset time between 4.5 and 24 hours (HOPE): protocol for a randomised, controlled, multicentre study16
Angioarchitecture and prognosis of pediatric intracranial pial arteriovenous fistula16
CCL17 exerts neuroprotection through activation of CCR4/mTORC2 axis in microglia after subarachnoid haemorrhage in rats16
Head-down position after reperfusion improves cerebral ischaemic injury in rat16
Cerebrovascular cinematic rendering of multisystemic smooth muscle dysfunction syndrome15
Framework for developing intracerebral haemorrhage recognition scales and technologies for hyperacute prehospital blood pressure lowering15
Quantitative histopathological analysis of thrombi retrieved by mechanical thrombectomy and their association with stroke aetiology15
Racial disparities in access to, and outcomes of, acute ischaemic stroke treatments in the USA15
Enhanced diagnostic workup increases pathological findings in patients with acute ischaemic stroke: results of the prospective HEBRAS study15
Extracellular vesicles bearing serum amyloid A1 exacerbate neuroinflammation after intracerebral haemorrhage15
Incidence and predictors of futile recanalisation after endovascular therapy in acute vertebrobasilar artery occlusion patients: insight from the ANGEL-ACT registry14
Src inhibition rescues FUNDC1-mediated neuronal mitophagy in ischaemic stroke14
Thrombolytic agents, more options, more challenges14
Endovascular therapy in acute anterior circulation large vessel occlusive patients with a large infarct core (ANGEL-ASPECT): protocol of a multicentre randomised trial14
Baseline systolic blood pressure and efficacy of dual antiplatelet in acute ischaemic stroke14
Loberamisal for Acute Ischaemic Stroke (LAIS): a multicentre, randomised, double-blind, parallel, placebo-controlled phase III clinical trial14
Dual regulation of Atf3 and Lonp1 as therapeutic targets in cerebral ischaemia-reperfusion injury13
Sex differences in the epidemiology of spontaneous and traumatic cervical artery dissections13
Extending the time window for intravenous tenecteplase in patients with distal medium vessel occlusions stroke: study protocol and rationale13
Rationale and design of Low-Frequency REpetitive TRanscranial Magnetic Stimulation Combined with Endovascular Treatment in ACute Ischaemic StrokE (RETRACE II): a randomised double-blind controlled mul13
Rationale and design of the GOLDEN BRIDGE II: a cluster-randomised multifaceted intervention trial of an artificial intelligence-based cerebrovascular disease clinical decision support system to impro13
Cerebral haemodynamics in symptomatic intracranial atherosclerotic disease: a narrative review of the assessment methods and clinical implications12
AI-Based STroke Risk fActor Classification and Treatment (ABSTRACT) study12
Central post-stroke pain: advances in clinical and preclinical research12
Advance Consent for participation in Acute Stroke Trials (ACTION): protocol for a feasibility study12
DRug-coated Balloon for Endovascular treatment of sYmptOmatic intracraNial stenotic Disease (DR. BEYOND): the protocol of a multicentre randomised trial12
Early blood pressure lowering and cerebral oedema in thrombolysis-treated stroke: secondary analysis of the ENCHANTED trial12
Outcomes of Onyx embolisation as primary treatment for intracranial dural arteriovenous fistulas over the past two decades11
Association between statin therapy and the risk of stroke in patients with moyamoya disease: a nationwide cohort study11
Clinical utility of measuring circulating glial fibrillary acidic protein in severe stroke11
Definitions of white matter hyperintensity change: impact on estimates of progression and regression11
BEST-BAO: a multicentre, prospective, randomised controlled trial of endovascular treatment with or without intravenous thrombolysis in acute ischaemic stroke due to basilar artery occlusion – study p11
Exosomes-mediated delivery of miR-486-3p alleviates neuroinflammation via SIRT2-mediated inhibition of mitophagy after subarachnoid hemorrhage10
Cisternostomy for malignant middle cerebral artery infarction: proposed pathophysiological mechanisms and preliminary results10
CSA declaration of next-generation reperfusion therapy for ischaemic stroke10
Secondary stroke evaluation in patients admitted for CRAO in a large national inpatient sample10
Exploring the relationship between embolic acute stroke distribution and supra-aortic vessel patency: key findings from an in vitro model study10
Oestrogen ameliorates blood-brain barrier damage after experimental subarachnoid haemorrhage via the SHH pathway in male rats10
Loss of life expectancy due to stroke and its subtypes in urban and rural areas in China, 2005–202010
Brain-targeted extracellular vesicles for anti-cuproptosis therapy in subarachnoid haemorrhage10
Efficacy of butylphthalide in preventing cognitive decline in ischaemic stroke survivors: a 12-month prospective following-up study10
Effect of intravenous alteplase before endovascular therapy for atherothrombotic stroke-related large vessel occlusion: subanalysis of the RESCUE AT-LVO registry9
Effect of a regional guideline-education initiative on dual antiplatelet therapy use in minor non-cardioembolic stroke: a pre–post analysis from the Shanghai Stroke Service System9
Intra-arterial thrombolytics during endovascular thrombectomy for acute ischaemic stroke in the MR CLEAN Registry9
Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-9
Neuronavigation-assisted stereotactic minimally invasive puncture with tenecteplase for the treatment of acute spontaneous deep intracerebral haemorrhage (NAS-TNK): rationale and design of a multicent9
Young stroke in Bangladesh: addressing rare cases with diagnostic challenges and much-needed solutions9
Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy9
COP27 climate change conference: urgent action needed for Africa and the world9
Surgical timing and long-term outcomes in patients with severe haemorrhagic spinal cord cavernous malformations9
Safety and efficacy of glibenclamide on cerebral oedema following aneurysmal subarachnoid haemorrhage: a randomised, double-blind, placebo-controlled clinical trial9
Incidence and prevalence of vascular cognitive impairment in China: a systematic review and meta-analysis9
Preclinical evaluation of ZL006-05, a new antistroke drug with fast-onset antidepressant and anxiolytic effects9
0.20654296875